‘Real-world’ effectiveness of smoking cessation treatments: a population study
Addiction2013Vol. 109(3), pp. 491–499
Citations Over TimeTop 10% of 2013 papers
Abstract
After adjusting for major confounding variables such as tobacco dependence, smokers in England who use a combination of behavioural support and pharmacotherapy in their quit attempts have almost three times the odds of success than those who use neither pharmacotherapy nor behavioural support. Smokers who buy nicotine replacement therapy over the counter with no behavioural support have similar odds of success in stopping as those who stop without any aid.
Related Papers
- → Smoking cessation treatment for COPD smokers: the role of pharmacological interventions(2015)11 cited
- → PRS4 EFFECTIVENESS OF VARENICLINE COMPARED TO BUPROPION AND NICOTINE REPLACEMENT THERAPY (NRT) FOR SMOKING CESSATION IN TWO SMOKING SPECIALIZED UNITS OF THE SPANISH PRIMARY CARE SETTING(2010)9 cited
- → Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials(2023)5 cited
- → A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline(2010)3 cited
- → A Retrospective Comparison of Varenicline Monotherapy Versus the Combination of Varenicline and Bupropion or Bupropion and Nicotine Patches in a VA Tobacco Cessation Clinic(2011)4 cited